Rusan Pharma Ltd

About Rusan Pharma Ltd

Rusan Pharma is a global pharmaceutical company specializing in addiction and pain management treatments. We manufacture and market a wide range of APIs and finished formulations, focusing on controlled substances (narcotic and psychotropic). Our facilities are GMP-approved by USFDA, Health Canada, EU, TGA, ANVISA, PIC/S, WHO, Russia, and SAHPRA. We hold CEP approvals for APIs like Buprenorphine, Fentanyl, Naltrexone, and Methadone, and also manufacture Naloxone, Nalbuphine, Apomorphine, and more, including transdermal patches and long-acting formulations.

Certifications
  • IN
  • 2015
    On CPHI since
  • 2
    Certificates
  • 500 - 999
    Employees
Company types
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Pharmaceutical Company (innovator finished products)
Contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from Rusan Pharma Ltd (45)

  • Addnok - N

    Product Addnok - N

    1.Better Patient Compliance 2.Rigorousely Tested by AIIMS (Delhi)
     3.Faster Onset Of Action

    Addnok-N® is an opioid medication known for its ceiling effect, which enhances safety in administration for patients. The product is available in ...
  • Addtrex

    Product Addtrex

    1. Reduces Cravings For Alcohol      2. Rapid Detoxification & quick onset of action  
     3.  Reduces risk of Relapse      
    4. Effective in both opioid & alcohol de- addiction 
  • Bioran Tablet

    Product Bioran Tablet

    Rusan Pharma Ltd offers a wide range of tablets which includes bioran tablet. Package size/ Form: N.100 tablet. Contact us for more information.
  • R-Meth

    Product R-Meth

    1. Opioid adverse effects (opioid neurotoxicity) 2.  Opioid induced tolerance and hyperalgesia  3. Treatment of moderate to severe pain not responsive to non-narcotic analgesics 
  • Rufenyl Injection  & Patch

    Product Rufenyl Injection & Patch

    Rufenyl Injection -
    1. Synthetic opioid 50-100 times more potent than morphine2. Can be used before, during, and after surgery to manage pain3. Can be used to patients who had developed tolerance to opiates 4. Often used in emergency rooms to manage pain from traumatic injuries

    Rufenyl...
  • Sangesic Tablet & Patch

    Product Sangesic Tablet & Patch

    Sangesic  Tablet :-1. Faster onset of action 
    2. Better patient Compliance 
    3. Long duration of action ( 6hrs tp 12 hrs.) 
    4. Effective in moderate to severe pain management

    Sangesic  Patch:- 
    1. Well tolerated 
    2. Continouse pain relie...
  • Sangesic Tablet & Patch

    Product Sangesic Tablet & Patch

    Rusan Pharma Ltd offers a wide range of tablets which includes diazepam 5 mg tablets. Package size/ Form: N.28/N.100 tablet. Contact us for more information.
  • Serulan Injection 2 ml.

    Product Serulan Injection 2 ml.

    Rusan Pharma Ltd offers a wide range of small volume parenterals which includes serulan injection 2 ml. Package size/ Form: N.50 injection. Contact us for more information.
  • Serulan Tablet

    Product Serulan Tablet

    Rusan Pharma Ltd offers a wide range of tablets which includes serulan tablet. Package size/ Form: N.100 tablet. Contact us for more information.
  • Silvacin Cream 15 gm.

    Product Silvacin Cream 15 gm.

    Rusan Pharma Ltd offers a wide range of creams/ gels & ointments which includes silvacin cream 15 gm.=. Package size/ Form: N.1 tube. Contact us for more information.
  • Silvacin Cream 30 gm.

    Product Silvacin Cream 30 gm.

    Rusan Pharma Ltd offers a wide range of creams/ gels & ointments which includes silvacin cream 30 gm. Package size/ Form: N.1 tube. Contact us for more information.
  • Sotalol 160 mg Tablets

    Product Sotalol 160 mg Tablets

    Rusan Pharma Ltd offers a wide range of tablets which includes sotalol 160 mg tablets. Package size/ Form: N.28 tablet. Contact us for more information.

Rusan Pharma Ltd Resources (2)

  • News Rusan Pharma’s API Plant in Ankleshwar (India) Receives USFDA GMP Approval

    RUSAN PHARMA PRIVATE LIMITED, an Indian pharmaceutical company specializing in addiction treatment and pain management, announced that its Active Pharmaceutical Ingredient (API) facility in Ankleshwar, Gujarat, received Good Manufacturing Practice (GMP) approval from the USFDA on May 29, 2024, following a rigorous inspection. This approval marks a significant milestone, enabling Rusan to expand into the US API market, particularly for niche APIs like Eflornithine and Nalmefene, while planning to add more APIs to its portfolio. Rusan Pharma’s Managing Director, Dr. Kunal Saxena, emphasized the company’s commitment to quality and global expansion. The USFDA approval complements Rusan's existing GMP certifications from Health Canada, the EU, and Brazil’s ANVISA, and aligns with the company’s vision to be a leader in addiction treatment and pain management. 
  • Technical Data Commercials APIs & APIs Under Development

    Commercials APIs  & APIs Under Development